Literature DB >> 34791916

Enteral nutrition ameliorates the symptoms of Crohn's disease in mice via activating special pro-resolving mediators through innate lymphoid cells.

Di Zhao1,2, Bo Yang1,2, Chen Ye1,2, Shaoyi Zhang1,2, Xiaoqiong Lv1,2, Qiyi Chen1,2.   

Abstract

Crohn's disease activates the inflammatory reactions to induce intestinal disorders. Enteral nutrition (EN) could exert general immunomodulatory effects. Cecal ligation and perforation (CLP) surgery was utilized to establish Crohn's disease mice models. Survival analysis, hematoxylin-eosin staining, flow cytometry, ELISA, Western blot and liquid chromatography-tandem MS were applied. Baicalein was added to inhibit lipoxygenases. The survival rate was restored and inflammatory injury, exudate neutrophils in peritoneal lavage and serum levels of IL-6 and TNF-α were ameliorated by EN treatment as compared with CLP treatment. EN also increased ILC-3 content, 5/15-LOX level and RvD1-RvD5 in peritoneal lavage. Baicalein reversed all the detected effects of EN except ILC-3 content. EN could activate special pro-resolving mediators (SPMs) through ILCs to mitigate injuries of Crohn's disease.

Entities:  

Keywords:  Crohn's disease; enteral nutrition; innate lymphoid cells; lipoxygenase; special pro-resolving mediators

Mesh:

Substances:

Year:  2021        PMID: 34791916      PMCID: PMC8762089          DOI: 10.1177/17534259211057038

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  42 in total

1.  Resolvin D3 and aspirin-triggered resolvin D3 are potent immunoresolvents.

Authors:  Jesmond Dalli; Jeremy W Winkler; Romain A Colas; Hildur Arnardottir; Chien-Yee C Cheng; Nan Chiang; Nicos A Petasis; Charles N Serhan
Journal:  Chem Biol       Date:  2013-02-21

2.  Novel benzoxanthene lignans that favorably modulate lipid mediator biosynthesis: A promising pharmacological strategy for anti-inflammatory therapy.

Authors:  Jana Gerstmeier; Christian Kretzer; Simone Di Micco; Laura Miek; Hannah Butschek; Vincenza Cantone; Rossella Bilancia; Roberta Rizza; Fabiana Troisi; Nunzio Cardullo; Corrado Tringali; Armando Ialenti; Antonietta Rossi; Giuseppe Bifulco; Oliver Werz; Simona Pace
Journal:  Biochem Pharmacol       Date:  2019-03-02       Impact factor: 5.858

Review 3.  Nutrition in Inflammatory Bowel Disease.

Authors:  Philipp Schreiner; Maude Martinho-Grueber; Diana Studerus; Stephan R Vavricka; Herbert Tilg; Luc Biedermann
Journal:  Digestion       Date:  2020-01-10       Impact factor: 3.216

Review 4.  Protectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome.

Authors:  Charles N Serhan; Jesmond Dalli; Romain A Colas; Jeremy W Winkler; Nan Chiang
Journal:  Biochim Biophys Acta       Date:  2014-08-17

5.  Vancomycin pre-treatment impairs tissue healing in experimental colitis: Importance of innate lymphoid cells.

Authors:  Di Zhao; Chenwen Cai; Qing Zheng; Shuang Jin; Dongjuan Song; Jun Shen; Zhihua Ran
Journal:  Biochem Biophys Res Commun       Date:  2016-12-27       Impact factor: 3.575

Review 6.  Crohn's disease.

Authors:  Joana Torres; Saurabh Mehandru; Jean-Frédéric Colombel; Laurent Peyrin-Biroulet
Journal:  Lancet       Date:  2016-12-01       Impact factor: 79.321

Review 7.  Pro-resolving lipid mediators are leads for resolution physiology.

Authors:  Charles N Serhan
Journal:  Nature       Date:  2014-06-05       Impact factor: 49.962

8.  Enteral Nutrition in Patients with Inflammatory Bowel Disease. Systematic Review, Meta-Analysis, and Meta-Regression.

Authors:  Jose M Comeche; Pablo Caballero; Ana Gutierrez-Hervas; Sofia García-Sanjuan; Iris Comino; Cesare Altavilla; Jose Tuells
Journal:  Nutrients       Date:  2019-11-04       Impact factor: 5.717

9.  Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway.

Authors:  Zenglin Liao; Jiajia Dong; Wei Wu; Ting Yang; Tao Wang; Lingli Guo; Lei Chen; Dan Xu; Fuqiang Wen
Journal:  Respir Res       Date:  2012-12-02

10.  Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals.

Authors:  Charles N Serhan; Song Hong; Karsten Gronert; Sean P Colgan; Pallavi R Devchand; Gudrun Mirick; Rose-Laure Moussignac
Journal:  J Exp Med       Date:  2002-10-21       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.